As Xarelto continues to spend millions of dollars in TV and mass media, another stream of money continues to follow the blood thinning medication—the dreaded Xarelto Lawsuit. With over 5,000 federally-filed lawsuits from across the United States against the manufacturer, consumers are finally getting the compensation they deserve for the patient deaths associated with the product—which prevents and treats blood clots. What’s more staggering is the blood thinner accounted for $1.8 billion in US sales in 2015 alone. A recent story revealed by The New York Times’ Katie Thomas also suggests that the drug’s developers, Johnson & Johnson and Bayer, may have left out some critical data when a peer reviewer at the New England Journal of Medicine asked for it.
What is Xarelto
Rivaroxaban, better known as Xarelto, is a prescription drug used to treat various medical issues. Most of its uses are related to blood clotting. While the drug has been deemed successful in stopping strokes caused by clotting, negative side effects can happen. Some of these side effects are not noticed until you stop using the drug.
What is the Xarelto Lawsuit and Why Are People Filing it?
The side effects from using this blood thinning prescription drug are at the center of many Xarelto Lawsuits around the country. The leading reason for filing these cases is that the pharmaceutical manufacturers marketed and promoted the drug without disclosing the costly side effects that go along with its use. When a company markets a drug and does not explain the risks associated with the use of their drug, it is considered negligence. The Xarelto Lawsuit specifically is causing consumers angst because additional materials are just recently coming to light including the potential cover-up of the drug’s research.
The aforementioned Xarelto commercial with Arnold Palmer and others. Plus a Xarelto Lawsuit Update.
You can always learn more about the case at Medical Claim Legal and their legal news blog.